Arq. Bras. Cardiol. 2020; 115(4): 708-711

COVID-19, Renin-Angiotensin System, Angiotensin-Converting Enzyme 2, and Nicotine: What is the Interrelation?

Jaqueline Ribeiro Scholz ORCID logo , Marcelo Antônio Cartaxo Queiroga Lopes, José Francisco Kerr Saraiva ORCID logo , Fernanda Consolim Colombo

DOI: 10.36660/abc.20200653

The World Health Organization (WHO) declared COVID-19, an infection caused by the new Coronavirus (SARS-CoV-2), as a pandemic on March 11, 2020. By the beginning of June, 7 million positive cases and around 400 thousand deaths from the disease had been reported worldwide. In the same period, Brazil accounted for approximately 700 thousand cases and 40 thousand deaths.

Although the virus can infect individuals of any age, so far the most serious cases have been described in people aged 55 and over, with associated comorbidities—many of them related to the cardiovascular system., Therefore, the medical community’s great concern about knowing how to act against COVID-19 is justifiable, especially in this population at higher risk and with many cardiovascular comorbidities, and the aim is reducing morbidity and mortality rates.,

[…]

COVID-19, Renin-Angiotensin System, Angiotensin-Converting Enzyme 2, and Nicotine: What is the Interrelation?

Comments

Skip to content